AMDCP Credit Designation: This session has been approved for a total of 1 Management credit hours toward certification as a Certified Medical Director in Long Term Care (CMD).
The American Medical Directors Association designates this educational activity fora maximum of 1 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity. Presenter(s): Jeffrey Nichols, MD; Louis Mudannayake, MD; Christie Teigland, PhD Disclosure(s): Jeffrey Nichols, MD, CMD has no relevant financial relationships to disclose. Dr.Nichols will discuss off-label use of Atypical Antipsychotics for treatment of behavioral disorders in Dementia. Their use will be discouraged, but their common use will be reviewed. Louis Mudannayake, MD has no relevant financial relationships to disclose. Christie Teigland, PhD has no relevant financial relationships to disclose. Dr. Teigland will discuss research related to off-label use of antipsychotic medications in the elderly, but no specific drug or drug research will be discussed, Session Description: This session will discuss anti-psychotic utilization trends and treatment patterns in nursing facility residents with dementia in the context of the FDA black box warning, tougher CMS regulations, and new guidelines based on recent evidence regarding safety and efficacy of the medications; contrast characteristics of residents treated vs. not treated with antipsychotics and weighing polypharmacy impacts; and evaluating approaches for avoiding and reducing unnecessary and off-label use of antipsychotic medications while effectively managing negative/disruptive behaviors in dementia residents. Learning Objectives:
Discuss antipsychotic utilization trends and treatment patterns in nursing facility residents with dementia in the context of the FDA blackbox warning, tougher CMS regulations, and new guidelines
Identify resident characteristics and outcomes associated withtreatment with antipsychotic medications and weigh polypharmacy impacts
Evaluate approaches for avoiding and reducing unnecessary andoff-label use of antipsychotic medications while effectively managingnegative/disruptive behaviors in dementia residents